Skip to main content
Back to path

Welcome to a Grasp lesson

Create a free account to keep studying and create your own study path.

Lesson 32

Correlating Deha-Prakriti with Genomic and Metabolomic Profiles

Recommended resources

Hello! Welcome to our lesson.

In our last session, we explored how to objectify the dynamic states of imbalance, Vikriti, by evaluating biomarkers for Agni (metabolism) and Ama (metabolic toxins). We saw that lipid profiles can reflect Agnibala, while inflammatory markers like CRP can quantify the systemic effects of Ama.

Today, we shift our focus from the dynamic state of Vikriti to the static, constitutional foundation of an individual: Deha-Prakriti. While Vikriti tells us what is wrong now, Prakriti tells us what an individual's inherent tendencies and susceptibilities are. For centuries, Prakriti assessment has been phenotypic—based on observing physical, physiological, and psychological traits. But can we find its signature in our very biology?

This brings us to our learning outcome: to evaluate biomarkers used to correlate Deha-Prakriti with genomic and metabolomic profiles. We will journey to the cutting edge of research where Ayurveda's holistic classification meets modern molecular biology. This is the heart of building the evidence-based, integrative practice you aim for, moving Ayurveda into the realm of predictive and personalized medicine.

From Ancient Phenotype to Modern Genotype: The Birth of Ayurgenomics

The idea that the three Doshas—Vata, Pitta, and Kapha—which define our Prakriti might have a basis in our genetic makeup is a revolutionary one. This hypothesis has given rise to a new trans-disciplinary field: Ayurgenomics.

Ayurgenomics seeks to correlate the phenotypic classification of Prakriti with objective, measurable molecular data from genomics, transcriptomics, proteomics, and metabolomics. It doesn't try to "prove" Ayurveda, but rather to use Ayurveda's powerful system of classification to better understand human biological variation.

Let's begin with two high-level perspectives on this integration.

Evidence-Based Ayurveda: How Ancient Medicine Meets Modern Science | Prof Bhushan Patwardhan

First, let's watch a brief clip from a talk by Prof. Bhushan Patwardhan, a pioneer in this field. He directly introduces the concept of Ayurgenomics and how it emerged from scientific inquiry into Prakriti.

Please watch the following segments: 00:22 - 01:02: Introduction to Ayurgenomics as a discipline. 21:42 - 22:12: A specific example of a genome-wide study that identified a gene (PGM1) associated with Pitta Prakriti.

Evidence-Based Ayurveda: How Ancient Wisdom + Modern Biology Revolutionizes Healthcare-Prof. Shankar

Next, Prof. Shankar provides a powerful conceptual framework. He explains that Ayurveda and modern biology are like two different windows looking at the same garden—the phenomenon of biological change. Ayurgenomics is the effort to combine these views for a more complete picture.

Please watch these two clips: 02:44 - 18:18: This longer section explains the core concept: Ayurveda offers a 'whole system' view, while biology offers a 'molecular' view. Understanding this distinction is crucial. Focus on the analogy of the eastern and western windows. 19:28 - 23:11: This part directly discusses Ayurgenomics and how Prakriti provides a framework to classify populations based on their genotype, a major challenge in modern genetics.

These perspectives establish a clear rationale: Prakriti provides a sophisticated, time-tested system for phenotyping (classifying observable traits) that can bring order to the vast complexity of genomic data. The "Ayurgenomics Approach" integrates these two worlds, as shown below.

The Ayurgenomics Approach: Integrating Prakriti with Multi-Omics Technologies
This diagram illustrates the research methodology of Ayurgenomics. It begins with population screening and `Prakriti`-based phenotyping. Biological samples are then analyzed using multi-omics technologies (genomics, transcriptomics, etc.) to discover molecular correlates, which are then validated.

Unlocking the Code: Genomic Biomarkers of Prakriti

Research in Ayurgenomics has started to reveal specific genetic markers that correlate with the three primary Prakriti types. These findings provide the first level of objective biological evidence for the Prakriti concept.

Let's dive into a review article that synthesizes many of these findings.

REVIEW ON PRAKRITI-BASED PERSONALIZED MEDICINE

The paper 'REVIEW ON PRAKRITI-BASED PERSONALIZED MEDICINE' provides a superb overview of the genomic basis of Prakriti. It details specific genetic variations linked to each Dosha type.

Please read the sections titled 'Genetic Correlations with Prakriti' and 'Transcriptomic and Proteomic Profiles'. Pay close attention to the specific genes mentioned for each Prakriti type (e.g., HLA variations, CYP genes, FTO, LEPR, IL-6, TNF-α).

Based on this and other research, we can summarize the key genomic correlates. These often involve Single Nucleotide Polymorphisms (SNPs), which are variations at a single position in a DNA sequence among individuals.

Key Genetic Associations:

  1. Vata Prakriti: Associated with movement, the nervous system, and catabolism.

    • Neurological & Stress Response: Variations in genes like DRD4 (dopamine receptor) and ADRB2 (beta-2 adrenergic receptor) align with the heightened neurological sensitivity and reactivity seen in Vata types.
    • Drug Metabolism: Polymorphisms in CYP2C19 (a key liver enzyme) are observed, potentially explaining variability in drug responses.
    • Circadian Rhythms: Variants in the CLOCK gene may relate to the irregular sleep and digestive patterns common in Vata.

  2. Pitta Prakriti: Associated with metabolism, transformation, and inflammation.

    • Inflammation: Over-expression or variants of genes for pro-inflammatory cytokines like IL-6 (Interleukin-6) and TNF-α (Tumor Necrosis Factor-alpha) correlate with the Pitta tendency towards inflammatory conditions.
    • Metabolism: The PGM1 gene, involved in glucose metabolism, has been strongly associated with Pitta. Variants in CYP2C19 related to rapid drug metabolism are also linked to the 'Tikshna Agni' of Pitta.

  3. Kapha Prakriti: Associated with structure, stability, and anabolism.

    • Metabolism and Obesity: Gene variants associated with obesity and metabolic syndrome are more common in Kapha types. These include FTO (fat mass and obesity-associated gene), LEPR (leptin receptor), FABP2, and APOE (involved in lipid metabolism).
    • Immunity: Certain HLA (Human Leukocyte Antigen) gene profiles suggest a tendency towards increased innate immune tolerance.
    • Drug Metabolism: Variants in CYP2C19 associated with slow drug metabolism align with the 'Manda Agni' of Kapha.

The image below conceptually links the fixed genetic blueprint (Janma Prakriti) with the expressed constitution, which is also influenced by epigenetic factors and lifestyle.

Genotype-Phenotype Relationship in Ayurvedic Constitution
This diagram shows how the genotype (Janma Prakriti) translates to the phenotype (Ayurvedic Constitution) through biological processes. It highlights the role of external factors like diet and stress, acting via epigenetics, in modulating this expression.

The Metabolic Signature: Metabolomic Profiles of Prakriti

While genomics reveals our constitutional blueprint, metabolomics provides a real-time snapshot of our physiological activity. It measures the levels of small-molecule metabolites (like sugars, lipids, amino acids) in our body. Studies have shown that different Prakriti types have distinct "metabolic signatures."

Prakriti: A tran-disciplinary approach to integrative medicine

The book chapter 'Prakriti: A tran-disciplinary approach to integrative medicine' clearly summarizes these findings. It lists the distinct metabolic patterns and provides a concise table of biomarkers.

Please read section '4.4 Distinct Metabolomic Patterns' and review Table 1.1 at the end of the chapter. This table is an excellent summary correlating genetic markers, metabolic profiles, and clinical implications for each Prakriti type.

Let's distill these findings into key metabolic biomarkers:

  • Vata Profile:

    • Low Body Mass Index (BMI).
    • Elevated cortisol levels, reflecting a tendency towards a heightened stress response.
    • Overall dominance of catabolic (breakdown) metabolic activity.

  • Pitta Profile:

    • High markers of oxidative stress, indicating intense metabolic activity that generates free radicals.
    • Elevated Low-Density Lipoprotein (LDL) cholesterol.
    • Indicators of rapid cellular energy production.

  • Kapha Profile:

    • Elevated leptin (the "satiety hormone," to which Kapha types may be resistant) and triglycerides.
    • Tendency towards insulin resistance.
    • High Body Mass Index (BMI) and a dominance of anabolic (building up) activity.

These metabolic patterns align perfectly with the classical descriptions of the Doshas and their corresponding disease predispositions (Vyadhi Kshamatva). For instance, the insulin resistance and high triglycerides in Kapha individuals provide a direct molecular link to their described susceptibility to Prameha (diabetes) and Medoroga (obesity).

Test your understanding!

A researcher is analyzing data from a clinical trial and has lost the Prakriti assessment for three subjects. Based on their biomarker data below, can you make an educated prediction of their dominant Prakriti?

  • Subject 1: Shows a variant of the FTO gene, has elevated fasting triglycerides, and a BMI of 31.
  • Subject 2: Has high baseline levels of the pro-inflammatory cytokine TNF-α and a CYP2C19 genotype associated with rapid drug metabolism.
  • Subject 3: Has chronically elevated serum cortisol levels and a gene expression profile showing upregulation of genes involved in neuro-reactivity.
Show answer
  • Subject 1: Kapha Prakriti. The combination of the FTO gene variant (linked to obesity), high triglycerides, and high BMI are all classic genomic and metabolomic signatures of the Kapha constitution.
  • Subject 2: Pitta Prakriti. High TNF-α points to a strong inflammatory tendency, and the rapid metabolism CYP2C19 genotype aligns with the 'Tikshna' nature of Pitta.
  • Subject 3: Vata Prakriti. Elevated cortisol is a key metabolic marker for Vata, and the upregulation of neuro-reactivity genes corresponds to the sensitive and active nervous system characteristic of Vata.

Conclusion

Today we have seen compelling evidence that the ancient Ayurvedic concept of Prakriti has tangible, measurable correlates in our modern biological data. Far from being a mere philosophical construct, Prakriti appears to represent a complex endophenotype with distinct genomic and metabolomic signatures.

Key Takeaways:

  • Ayurgenomics is the field dedicated to integrating Ayurvedic Prakriti-based classification with modern 'omics' technologies to understand human individuality.
  • Genomic Biomarkers: Specific genetic variations (SNPs) and gene expression patterns are associated with each Prakriti.
    • Vata: Linked to genes for neuro-reactivity (DRD4), stress response (ADRB2), and circadian rhythm (CLOCK).
    • Pitta: Linked to genes for inflammation (TNF-α, IL-6) and rapid metabolism (PGM1, CYP2C19).
    • Kapha: Linked to genes for obesity (FTO), lipid metabolism (APOE), and slow metabolism.
  • Metabolomic Biomarkers: Each Prakriti exhibits a unique metabolic profile.
    • Vata: High cortisol, catabolic state.
    • Pitta: High oxidative stress, high LDL.
    • Kapha: High triglycerides, insulin resistance, anabolic state.
  • Integrative Potential: This correlation allows Prakriti to be used as a powerful stratification tool in research and clinical practice, paving the way for truly personalized and predictive medicine.

Preview of the Next Lesson:

We have now established that objective biomarkers exist for both the dynamic state of Vikriti (Agni/Ama) and the static constitution of Prakriti. The crucial next step is to ask: How do we put this all together? In our next lesson, we will address the learning outcome: "Propose a conceptual framework for integrating Prakriti assessment into modern precision medicine." We will move from evaluating the evidence to designing a system for its practical application.